98%
921
2 minutes
20
Purpose Of Review: This review outlines current model systems of HIV latency and their analysis with single-cell omics technologies. Previous studies have used bulk analyses of infected cell cultures to determine mechanisms of HIV transcription and to identify targets associated with HIV latency in vitro . However, heterogeneity in cell populations creates a barrier to the effectiveness of latency reversing agents. Single cell approaches promise to accelerate our understanding of how the host cell environment regulates complex behaviors of the HIV provirus.
Recent Findings: Several recent papers have applied cutting edge single cell omics methods to model systems of HIV latency, including scRNAseq and scATACseq, as well as multiomic methods such as DOGMAseq and ECCITEseq. These papers have revealed complex heterogeneity in latently infected cells but have also led to the identification of several new host cell genes that regulate HIV latency.
Summary: Single-cell technologies provide sensitive detection of cellular subpopulations that contribute to proviral reactivation and latency, making them advantageous to apply to widely used cell line and primary cell models of HIV latency. These studies have increased our understanding of HIV latency model systems and generated novel hypotheses which can be tested in clinical samples from people with HIV.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321199 | PMC |
http://dx.doi.org/10.1097/COH.0000000000000959 | DOI Listing |
Chaos
September 2025
School of Mathematical Sciences, Capital Normal University, Beijing 100048, China.
In this paper, we propose a general latent HIV infection model with general incidence and three distributed delays. We start with the analysis of the proposed model by establishing the positivity and boundedness of solutions and calculating basic reproduction number R0. Then, we show that the infection-free equilibrium is globally asymptotically stable when R0<1 (is globally attractive when R0=1), while the disease is uniformly persistent when R0>1.
View Article and Find Full Text PDFFront Cell Infect Microbiol
September 2025
Fundació Lluita contra les Infeccions, Badalona, Spain.
Background: The intestinal microbiota composition has been linked to neurocognitive impairment in people with HIV (PWH). However, the potential interplay of microbial species and related metabolites, particularly in the context of an HIV cure strategy remains underexplored. The BCN02 trial evaluated the impact of romidepsin (RMD), used as a HIV-1 latency reversing agent and with reported beneficial neurological effects, combined with the MVA.
View Article and Find Full Text PDFRinsho Ketsueki
September 2025
Department of Hematology, Graduate School of Medicine, Kyoto University.
Antiretroviral therapy (ART) is a well-established treatment for HIV infection that suppresses viral replication by inhibiting viral enzymatic activity, thereby preventing progression to immunodeficiency. However, discontinuation of ART typically leads to rapid viral rebound within weeks, due to the reactivation of latent HIV from long-lived reservoirs such as resting CD4 T cells. Eradication of these latent reservoirs is essential to achieve a cure for HIV.
View Article and Find Full Text PDFPLoS Pathog
September 2025
Department of Microbiology and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America.
Antiretroviral therapy (ART) has dramatically improved the clinical prognosis for people with HIV and prevents HIV transmission. However, ART does not cure HIV infection because of a persistent, latent viral reservoir in long-lived cells such as central memory CD4+ T (TCM) cells. Eliminating or preventing reservoir formation will require a better understanding of HIV-1 latency establishment.
View Article and Find Full Text PDFCurr Opin HIV AIDS
August 2025
Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York.
Purpose Of Review: Persistent HIV reservoirs within lymphoid tissues represent a major obstacle to achieving an HIV cure. This review examines current and emerging assays used to visualize, characterize, and quantify these reservoirs. Recent advancements in imaging, sequencing, and single-cell technologies are providing unprecedented detail about the composition, landscape and behavior of HIV reservoirs.
View Article and Find Full Text PDF